NCT04837755

Brief Summary

The CORSAAR study is an observational, prospective study to investigate the natural biology of COVID-19

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
300

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2020

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

April 6, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

April 8, 2021

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

May 25, 2025

Status Verified

May 1, 2025

Enrollment Period

5.8 years

First QC Date

April 6, 2021

Last Update Submit

May 21, 2025

Conditions

Covid19

Outcome Measures

Primary Outcomes (1)

  • Correlation of biomarkers with mortality and disease subgroups

    2 years after initial disease

Interventions

Cytokine measurementsDIAGNOSTIC_TEST

The serum concentrations of multiple cytokines are measured.

Eligibility Criteria

Age0 Years - 110 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All COVID-19 patients in the State of Saarland

You may qualify if:

  • all form of COVID-19 including long-COVID-19

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Saarland University

Homburg, Saarland, 66421, Germany

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

Serum, Plasma, EDTA, PaxGene

MeSH Terms

Conditions

COVID-19

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Robert Bals, MD PhD

CONTACT

+4968411615051robert.bals@uks.eu

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

April 6, 2021

First Posted

April 8, 2021

Study Start

March 1, 2020

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

May 25, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will share
Shared Documents
STUDY PROTOCOL

Locations

DE(1)